Fundraising Fox

Vitruvias Therapeutics

Auburn, US · Founded 2013 · Delaware corporation

Vitruvias Therapeutics was a pharmaceutical company; it has ceased operations, and its products are now owned and/or distributed by H2-Pharma LLC.

Founders & leadership

BM
Bryce M HarveyExecutive
RD
Roger D GrabenExecutive
CL
Carl L WhatleyExecutive
CL
Carl Leo Whatley, Jr.General Manager

Board

JW
Jason WildBoard director
MA
Michael AltmanBoard director
ES
Edward SchutterBoard director

Reported raises · per SEC filings

Form D private placements

$11.7M disclosed across 2 rounds · 2014–2017

$11.5MraisedJan 2018 · 23 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Bryce M HarveyExecutive Officer, Director
  • Jason WildDirector
  • Roger D GrabenExecutive Officer
  • Michael AltmanDirector
  • Edward SchutterDirector
  • Carl L WhatleyExecutive Officer, Director
Offering amount
$11.5M
Amount sold
$11.5M
Minimum investment
$25K
Proceeds to insiders
$1.5M
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$200KraisedJul 2014 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Carl Leo Whatley, Jr.Executive Officer
  • Bryce M HarveyExecutive Officer
Offering amount
$2.5M
Amount sold
$200K
Minimum investment
$25K
Proceeds to insiders
$595K
First sale
Jul 2014
Incorporated
Limited Liability Company, Delaware, 2013
Federal exemptions
05, 06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Vitruvias Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Vitruvias Therapeutics do?
Vitruvias Therapeutics was a pharmaceutical company; it has ceased operations, and its products are now owned and/or distributed by H2-Pharma LLC.
How much funding has Vitruvias Therapeutics raised?
Vitruvias Therapeutics has disclosed $11.7M raised across 2 rounds.
Where is Vitruvias Therapeutics headquartered?
Vitruvias Therapeutics is headquartered in Auburn, US.